On July 22, 2026, Nasdaq notified the company that it determined to delist its securities from The Nasdaq Capital Market after the bid price stayed below $1.00 for 30 consecutive business days, and the company is ineligible for a 180-day cure period due to a recent reverse split. Unless appealed by July 29, 2026, trading will be suspended July 31, 2026; the company will request a hearing, which will stay delisting during the process.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.